GlobeNews Wire

New Study Shows Americans Prefer Cold Filtered Water at HomeGlacier Fresh Responds With Coolon

NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Americans’ relationship with drinking water is changing rapidly. Recent survey data reveal…

1 week ago

ICPO and UroTeragLATAM signed a strategic agreement to accelerate Theranostics for urological cancer in Latin America

The partnership strengthens education, innovation, and patient access by combining global expertise with regional leadership in precision oncology. February 27,…

1 week ago

Orion Group Financial Statement documents 2025 and Remuneration Report published

ORION CORPORATION STOCK EXCHANGE RELEASE – ANNUAL FINANCIAL REPORT 27 FEBRUARY 2026 at 11.05 EET         Orion Group Financial Statement documents…

1 week ago

Genenta Advances Transformation into Saentra Forge, Strengthens ATC Governance and Expands Strategic Industrial Consolidation Platform

Nature Medicine Accepts Manuscript Highlighting Clinical Results from the Company’s Glioblastoma Trial February 27, 2026 04:00 ET  | Source: GENENTA…

1 week ago

weBoost Named Winner in 2026 Merit Awards for Telecom & Wireless

ST. GEORGE, Utah, Feb. 26, 2026 (GLOBE NEWSWIRE) -- weBoost, the leader in cell signal booster technology, has been recognized…

1 week ago

Ataccama Launches Agentic Data Observability to Extend Market-Leading Data Trust Platform

BOSTON, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Ataccama, the data trust company, today announced Agentic Data Observability in Ataccama ONE,…

1 week ago

LIS Technologies Inc. Announces its Flagship Commercial Laser-Based Uranium Enrichment Headquarters on LIST Island as the Site of Project F.U.E.L to Shape the Future of U.S. Laser-Based Enrichment

Oak Ridge, Tennessee, Feb. 26, 2026 (GLOBE NEWSWIRE) -- LIS Technologies Inc. (“LIST” or “the Company”), a proprietary developer of…

1 week ago

Fate Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

Outpatient treatment enabled under FT819-102 autoimmune basket protocol with patients now treated with FT819 off-the-shelf CAR T-cell therapy as same-day…

1 week ago

Femasys Announces FemBloc Permanent Birth Control Has Achieved MDSAP Certification, Advancing Global Market Access

-- FemBloc becomes the latest Femasys product to achieve MDSAP certification, building on a proven track record of compliance --…

1 week ago

The International Myeloma Foundation Invites the Myeloma Community to Demonstrate the Spirit of #MoreThanMyeloma for 2026 Myeloma Action Month

STUDIO CITY, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Every March, the International Myeloma Foundation (IMF) leads Myeloma Action Month…

1 week ago